Search research articles
Contact Us
Filters
Showing results (551-560 of 678) with videos related to
Page
of 68
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 8, 2016
Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy
Maria Stamelou, Jakob Schöpe, Stefan Wagenpfeil, et al.
Neurology
|
July 25, 2012
Career mentorship for young neurologists in Europe
Ross W Paterson, Gunhild Waldermar, K Ray Chaudhuri, et al.
JAMA Neurology
|
December 4, 2023
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease
Shijun Yan, Cheng Jiang, Annette Janzen, et al.
Science Advances
|
November 12, 2020
Determinants of seeding and spreading of α-synuclein pathology in the brain
Martin T Henrich, Fanni F Geibl, Harini Lakshminarasimhan, et al.
Health and Quality of Life Outcomes
|
March 19, 2013
Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease
Judith Dams, Jens Klotsche, Bernhard Bornschein, et al.
Scientific Reports
|
September 15, 2017
Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells
Matthias Höllerhage, Claudia Moebius, Johannes Melms, et al.
European Journal of Neurology
|
February 17, 2019
Abnormal α-synuclein deposits in skin nerves: intra- and inter-laboratory reproducibility
V Donadio, K Doppler, A Incensi, et al.
Cell Death & Disease
|
November 16, 2019
Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons
Goutham K Ganjam, Kathrin Bolte, Lina A Matschke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 23, 2007
Nigrostriatal dysfunction in X-linked dystonia-parkinsonism (DYT3)
Björn Tackenberg, Aline Metz, Marcus Unger, et al.
European Journal of Endocrinology
|
November 4, 2011
Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study
F Jakob, H Oertel, B Langdahl, et al.
Page
of 68
Search research articles
Search
Showing results (551-560 of 678) with videos related to
Sort By:
Page
of 68
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 8, 2016
Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy
Maria Stamelou, Jakob Schöpe, Stefan Wagenpfeil, et al.
Neurology
|
July 25, 2012
Career mentorship for young neurologists in Europe
Ross W Paterson, Gunhild Waldermar, K Ray Chaudhuri, et al.
JAMA Neurology
|
December 4, 2023
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease
Shijun Yan, Cheng Jiang, Annette Janzen, et al.
Science Advances
|
November 12, 2020
Determinants of seeding and spreading of α-synuclein pathology in the brain
Martin T Henrich, Fanni F Geibl, Harini Lakshminarasimhan, et al.
Health and Quality of Life Outcomes
|
March 19, 2013
Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease
Judith Dams, Jens Klotsche, Bernhard Bornschein, et al.
Scientific Reports
|
September 15, 2017
Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells
Matthias Höllerhage, Claudia Moebius, Johannes Melms, et al.
European Journal of Neurology
|
February 17, 2019
Abnormal α-synuclein deposits in skin nerves: intra- and inter-laboratory reproducibility
V Donadio, K Doppler, A Incensi, et al.
Cell Death & Disease
|
November 16, 2019
Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons
Goutham K Ganjam, Kathrin Bolte, Lina A Matschke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 23, 2007
Nigrostriatal dysfunction in X-linked dystonia-parkinsonism (DYT3)
Björn Tackenberg, Aline Metz, Marcus Unger, et al.
European Journal of Endocrinology
|
November 4, 2011
Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study
F Jakob, H Oertel, B Langdahl, et al.
Page
of 68